{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-027086","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.924337+00:00","generated_at":"2026-05-31T21:10:28.807699+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Oncocyte gets Nasdaq notice of prior noncompliance and regained compliance after director death","bullets":["Director Alfred D. Kingsley died April 25, 2024, causing noncompliance with Nasdaq independent board and audit committee rules.","Effective July 1, 2024, director Andrew Arno was deemed independent and appointed to the audit committee, restoring compliance.","Nasdaq Staff confirmed compliance on July 8, 2024; no further action required.","The company had previously disclosed the independence determination in a Form 8-K filed July 5, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-027086","json":"https://secwatch.observer/filing/0001493152-24-027086.json","markdown":"https://secwatch.observer/filing/0001493152-24-027086.md","text":"https://secwatch.observer/filing/0001493152-24-027086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224027086/0001493152-24-027086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224027086/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:10:28.807699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}